Ocugen, Inc. (OCGN)

Ocugen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-63.08	-86.8	-58.37	-34.37	-20.24
Depreciation & Amortization	1.24	1.07	0.59	0.29	0.31
Share-Based Compensation	9.22	10.54	6.96	0.66	0.88
Other Operating Activities	-9.44	15.11	2.88	6.16	2.16
Operating Cash Flow	-62.05	-60.08	-47.94	-14.71	-16.89
Capital Expenditures	-10.48	-4.46	-0.94	-0.31	-0.03
Acquisitions	0	0	-0.13	0	-2.33
Change in Investments	13.55	-12.51	0	0	0
Other Investing Activities	-	-	-0.75	-	-
Investing Cash Flow	3.08	-16.97	-1.82	-0.31	-2.36
Share Issuance / Repurchase	20.45	59.02	120.69	36.35	1.14
Debt Issued / Paid	0.43	0.46	-0.01	-4.73	23.93
Financing Cash Flow	20.88	59.48	120.68	31.61	25.07
Exchange Rate Effect	-0.01	0.03	0	0	0
Net Cash Flow	-38.1	-17.55	70.92	16.6	5.82
Free Cash Flow	-72.53	-64.54	-48.88	-15.02	-16.92
Free Cash Flow Margin	-1201.62%	-2593.89%	-	-34920.93%	-
Free Cash Flow Per Share	-0.30	-0.30	-0.25	-0.13	-1.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).